Cargando…

Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program

The DIAMOND study demonstrated that the addition of real-time continuous glucose monitoring (rtCGM) effectively lowers glycated hemoglobin (HbA(1c)) in patients with type 1 (T1D) and type 2 diabetes (T2D), treated with multiple daily injections (MDI). This post hoc analysis investigated whether DIAM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Billings, Liana K., Parkin, Christopher G., Price, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2018
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080123/ https://www.ncbi.nlm.nih.gov/pubmed/30044123 http://dx.doi.org/10.1089/dia.2018.0163

Ejemplares similares

Glycemic Improvement Using Continuous Glucose Monitoring by Baseline Time in Range: Subgroup Analyses from the DIAMOND Type 1 Diabetes Study
por: Calhoun, Peter, et al.
Publicado: (2021)

Magnitude of Glycemic Improvement in Patients with Type 2 Diabetes Treated with Basal Insulin: Subgroup Analyses from the MOBILE Study
por: Davis, Georgia, et al.
Publicado: (2022)

IDegLira Improves Glycemic Control in Japanese Patients with Uncontrolled Type 2 Diabetes on Premixed Insulin Therapy
por: Watada, Hirotaka, et al.
Publicado: (2019)

Glycated albumin is correlated with glycated hemoglobin in type 2 diabetes
por: Ciobanu, Dana Mihaela, et al.
Publicado: (2019)

Predictive factors of durability to sitagliptin: Slower reduction of glycated hemoglobin, older age and higher baseline glycated hemoglobin
por: Chung, Hye Soo, et al.
Publicado: (2014)

Year-Long Trend in Glycated Hemoglobin Levels in Patients with Type 2 Diabetes during the COVID-19 Pandemic
por: Jin, Jonghwa, et al.
Publicado: (2021)

Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis
por: Kobayashi, Hiroki, et al.
Publicado: (2016)

Glycated hemoglobin at diagnosis of type 1 diabetes and at follow‐up in children and adolescents during the COVID‐19 pandemic in Germany
por: Kamrath, Clemens, et al.
Publicado: (2022)

Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study)
por: Toyoshima, Marcos Tadashi Kakitani, et al.
Publicado: (2023)

Genetic Determinants of Glycated Hemoglobin in Type 1 Diabetes
por: Syreeni, Anna, et al.
Publicado: (2019)

Prognostic value of glycated hemoglobin in colorectal cancer
por: Ferroni, Patrizia, et al.
Publicado: (2016)

Glycaemic efficacy of an expanded dose range of dulaglutide according to baseline glycated haemoglobin (HbA1c) subgroup: Post hoc analysis of AWARD‐11
por: Frias, Juan P., et al.
Publicado: (2021)

Glycated Hemoglobin, Fasting Insulin and the Metabolic Syndrome in Males. Cross-Sectional Analyses of the Aragon Workers’ Health Study Baseline
por: Saravia, Gabriela, et al.
Publicado: (2015)

Subgroup Analysis Stratified by Baseline Pancreatic β-cell Function in a Japanese Study of Dulaglutide in Patients with Type 2 Diabetes
por: Iwamoto, Noriyuki, et al.
Publicado: (2017)

Glycated hemoglobin and red blood cell indices in non-diabetic pregnant women
por: Abass, Awad-Elkareem, et al.
Publicado: (2017)

Correlation Between Glycated Hemoglobin and Homa Indices in Type 2 Diabetes Mellitus: Prediction of Beta-Cell Function from Glycated Hemoglobin
por: Al-Hakeim, Hussein Kadhem, et al.
Publicado: (2015)

Postprandial Glucagon Reductions Correlate to Reductions in Postprandial Glucose and Glycated Hemoglobin with Lixisenatide Treatment in Type 2 Diabetes Mellitus: A Post Hoc Analysis
por: Ahrén, Bo, et al.
Publicado: (2016)

Additional Use of Glycated Hemoglobin for Diagnosis of Type 2 Diabetes in People Undergoing Coronary Angiography Reveals a Subgroup at Increased Cardiovascular Risk
por: Silbernagel, Guenther, et al.
Publicado: (2011)

Glycated Albumin and Glycated Hemoglobin Are Influenced Differently by Endogenous Insulin Secretion in Patients With Type 2 Diabetes
por: Koga, Masafumi, et al.
Publicado: (2010)

The Glycated Albumin to Glycated Hemoglobin Ratio Might Not Be Associated with Carotid Atherosclerosis in Patients with Type 1 Diabetes
por: Kim, Wonjin, et al.
Publicado: (2014)

Glycated Hemoglobin and All-Cause Mortality in Korean Type 2 Diabetes
por: An, Mi Suk, et al.
Publicado: (2017)

Cardiovascular Outcomes with Finerenone According to Glycemic Status at Baseline and Prior Treatment with Newer Antidiabetics among Patients with Type 2 Diabetes Mellitus
por: Patoulias, Dimitrios, et al.
Publicado: (2022)

The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study
por: Elliott, Tom, et al.
Publicado: (2021)

Glycated Hemoglobin Value for Fasting Plasma Glucose of 126 mg/dL in Korean: The 2011 Korea National Health and Nutrition Examination Survey
por: Kim, Jung Min, et al.
Publicado: (2014)

Efficacy and safety of the fixed‐ratio combination of insulin degludec and liraglutide by baseline glycated hemoglobin, body mass index and age in Japanese individuals with type 2 diabetes: A subgroup analysis of two phase III trials
por: Komatsu, Mitsuhisa, et al.
Publicado: (2021)

The Optimal Cutoff Value of Glycated Hemoglobin for Detection of Diabetic Retinopathy
por: Kim, Jung Min, et al.
Publicado: (2015)

The value of glycated hemoglobin as predictor of organ dysfunction in patients with sepsis
por: Lee, Young Seok, et al.
Publicado: (2019)

Efficacy and safety of oral semaglutide by baseline age in Japanese patients with type 2 diabetes: A subgroup analysis of the PIONEER 9 and 10 Japan trials
por: Yamada, Yuichiro, et al.
Publicado: (2021)

Effect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline Characteristics
por: Kolb, Martin, et al.
Publicado: (2023)

Correlation of long-term glycemic control as measured by glycated hemoglobin with serum angiopoietin-like 6 protein levels in type 2 diabetes mellitus patients
por: Sharma, Vikaas, et al.
Publicado: (2017)

Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment
por: Miya, Aika, et al.
Publicado: (2020)

Pitavastatin improves glycated hemoglobin in patients with poorly controlled type 2 diabetes
por: Huang, Chung‐Huei, et al.
Publicado: (2016)

Correlation between Glycated Hemoglobin and Triglyceride Level in Type 2 Diabetes Mellitus
por: Naqvi, Syeda, et al.
Publicado: (2017)

Association of Longitudinal Values of Glycated Hemoglobin With Cardiovascular Events in Patients With Type 2 Diabetes and Multivessel Coronary Artery Disease
por: Rezende, Paulo Cury, et al.
Publicado: (2020)

Type 2 diabetes pharmacotherapy trends in high‐risk subgroups
por: Bae, Jay, et al.
Publicado: (2022)

Validity of Glycated Hemoglobin in Screening and Diagnosing Type 2 Diabetes Mellitus in Chinese Subjects
por: Yu, Yun, et al.
Publicado: (2012)

The variability of glycated hemoglobin is associated with renal function decline in patients with type 2 diabetes
por: Lee, Chia-Lin, et al.
Publicado: (2020)

Associations of Dietary Patterns and Nutrients with Glycated Hemoglobin in Participants with and without Type 1 Diabetes
por: Basu, Arpita, et al.
Publicado: (2021)

Association between hyperuricemia and glycated hemoglobin in type 2 diabetes at the District Hospital of Dschang
por: Donkeng, Martial, et al.
Publicado: (2021)

Assessment of glycemic control using glycated hemoglobin among diabetic patients in Jimma University specialized hospital, Ethiopia
por: Cheneke, Waqtola, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tnj5ra9ds413o0ojcmbfbpo28l